CompoAtlas

Qing Bi Tang

Natural health product licensed in Canada

Other names
Pueraria Nasal Combination
Licence holder
STPCA dba Sun Ten Laboratories
NPN or DIN-HM
80112120
Status
Active licence
Licence date
15 August 2021
Revision date
Not provided
Form
Granules
Route of administration
Orale
Application type
Traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Gypsum Fibrosum

Extraction ratio : 4.75:1

Dry plant equivalent : 114.29 mg

24.06 mgNot calculated
Ligusticum sinense cv. chuanxiong

Source : Rhizome

Extract : Matériel brut sec

Extraction ratio : 4.75:1

Dry plant equivalent : 85.73 mg

18.05 mgNot calculated
Ephedra sinica

Source : Tige

Extract : Matériel brut sec

Extraction ratio : 4.75:1

Dry plant equivalent : 171.43 mg

36.09 mgNot calculated
Coix lacryma-jobi var. ma-yuen

Source : Graine

Extract : Matériel brut sec

Extraction ratio : 4.75:1

Dry plant equivalent : 285.71 mg

60.15 mgNot calculated
Paeonia lactiflora

Source : Racine

Extract : Matériel brut sec

Extraction ratio : 4.75:1

Dry plant equivalent : 171.43 mg

36.09 mgNot calculated
Glycyrrhiza uralensis

Source : Racine

Extract : Matériel brut sec

Extraction ratio : 4.75:1

Dry plant equivalent : 57.14 mg

12.03 mgNot calculated
Zingiber officinale

Source : Rhizome

Extract : Matériel brut sec

Extraction ratio : 4.75:1

Dry plant equivalent : 85.73 mg

18.05 mgNot calculated
Pueraria montana var. lobata

Source : Racine

Extract : Matériel brut sec

Extraction ratio : 4.75:1

Dry plant equivalent : 342.86 mg

72.18 mgNot calculated
Ziziphus jujuba

Source : Fruit

Extract : Matériel brut sec

Extraction ratio : 4.75:1

Dry plant equivalent : 114.29 mg

24.06 mgNot calculated
Cinnamomum aromaticum

Extract : Matériel brut sec

Extraction ratio : 4.75:1

Dry plant equivalent : 142.87 mg

30.08 mgNot calculated
Rheum tanguticum

Source : Racine et rhizome

Extract : Matériel brut sec

Extraction ratio : 4.75:1

Dry plant equivalent : 85.73 mg

18.05 mgNot calculated
Platycodon grandiflorus

Source : Racine

Extract : Matériel brut sec

Extraction ratio : 4.75:1

Dry plant equivalent : 257.14 mg

54.14 mgNot calculated
Magnolia biondii

Source : Fleur

Extract : Matériel brut sec

Extraction ratio : 4.75:1

Dry plant equivalent : 257.14 mg

54.14 mgNot calculated

Non-medicinal ingredients

Amidon de maïs, Cellulose en poudre

PopulationAgeQuantity per servingFrequency
AdultesNot specified3.5 Portions3 days

Uses authorised in Canada

Text supplied in English because no French text is available.

Product based on the theory of Traditional Chinese Medicine.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80112120

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Glycyrrhiza uralensis
    Read the warning, when it applies and the studies cited

    DEGLYCYRRHIZINATED LICORICE Buccal

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 October 2025

    Deglycyrrhizinated Licorice Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 January 2025

    LICORICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Cough relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Gastritis relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant (EMA 2012).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

  • Zingiber officinale
    Read the warning, when it applies and the studies cited

    GINGER - ZINGIBER OFFICINALE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line